| __timestamp | Amicus Therapeutics, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 406114000 |
| Thursday, January 1, 2015 | 47269000 | 449119000 |
| Friday, January 1, 2016 | 71151000 | 502892000 |
| Sunday, January 1, 2017 | 88671000 | 544156000 |
| Monday, January 1, 2018 | 127200000 | 683530000 |
| Tuesday, January 1, 2019 | 169861000 | 736942000 |
| Wednesday, January 1, 2020 | 156407000 | 854233000 |
| Friday, January 1, 2021 | 192710000 | 1451683000 |
| Saturday, January 1, 2022 | 213041000 | 1416967000 |
| Sunday, January 1, 2023 | 275270000 | 1343105000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, understanding the financial dynamics of companies is crucial. Over the past decade, Jazz Pharmaceuticals plc and Amicus Therapeutics, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Jazz Pharmaceuticals consistently outpaced Amicus Therapeutics, with SG&A expenses peaking at approximately 1.45 billion in 2021, a staggering 400% increase from 2014. In contrast, Amicus Therapeutics saw a more modest rise, with expenses growing by about 1,230% over the same period, reaching around 275 million in 2023. This disparity highlights Jazz's aggressive expansion and operational scale compared to Amicus's more conservative growth strategy. Such insights are invaluable for investors and stakeholders aiming to gauge the financial health and strategic direction of these pharmaceutical giants.
Eli Lilly and Company vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc. Trends and Insights
GSK plc vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or Jazz Pharmaceuticals plc
Alnylam Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
BioMarin Pharmaceutical Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Alpine Immune Sciences, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Jazz Pharmaceuticals plc vs Xencor, Inc.: SG&A Expense Trends
Bausch Health Companies Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Amicus Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.